Influence of pt3 subgroups on outcome of R0-resected colorectal tumors

Southern Medical Journal

Volumn 104, Issue 11, 2011, Pages 722-730

  Mrak, Karl ^a   Jagoditsch, Michael ^a   Leibl, Sebastian ^a   Klingler, Anton ^a   Tschmelitsch, Jörg ^a  

^a KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

Author keywords

Colorectal cancer; Infiltration depth; PT3 substaging; Recurrence rates; Survival rates

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INFILTRATION; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; PT3 CLASSIFICATION; RECTUM CANCER; SURVIVAL RATE;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 80155201202     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3182321271     Document Type: Article

References (25)

1. Merkel S, Mansmann U, Papadopoulos T, et al. The prognostic inhomogeneity of colorectal carcinomas stage III. A proposal for subdivision of stage III. Cancer 2001;92:2754-2759. (Pubitemid 33091911)
2. Miyoshi M, Ueno H, Hashiguchi Y, et al. Extent of mesorectal tumor invasion as a prognostic factor after curative surgery for T3 rectal cancer patients. Ann Surg 2006;243:492-498.
3. Willett CG, Badizadegan K, Ancukiewicz M, et al. Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum 1999;42:167-173. (Pubitemid 29085151)
4. Burdy G, Panis Y, Alves A, et al. Identifying patients with T3-T4 nodenegative colon cancer at high risk of recurrence. Dis Colon Rectum 2001; 44:1682-1688. (Pubitemid 33126988)
5. Tsai HL, Cheng KI, Lu CY, et al. Prognostic significance of depth of invasion, vascular invasion and numbers of lymph node retrievals in combination for patients with stage II colorectal cancer undergoing radical resection. J Surg Oncol 2008;97:383-387.
6. Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:979-994. (Pubitemid 30602039)
7. Steel MC, Woods R, Mackay JM, et al. Extent of mesorectal invasion is a prognostic indicator in T3 rectal carcinoma. ANZ J Surg 2002;72:483-487. (Pubitemid 34779377)
8. Cawthorn SJ, Parums DV, Gibbs NM, et al. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet 1990;335:1055-1059. (Pubitemid 20148648)
9. Katsumata D, Fukui H, Ono V, et al. Depth of tumor invasion in locally advanced rectal cancer correlates with patients prognosis: the usefulness of elastic stain for its measurement. Surg Today 2008;8:115-122. (Pubitemid 351197903)
10. Picon AI, Moore HG, Sternberg SS, et al. Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy. Int J Colorectal Dis 2003;18:487-492. (Pubitemid 37265859)
11. Yoshida K, Yoshimatsu K, Otani T, et al. The depth of tumor invasion beyond the outer border of the muscularis propria as a prognostic factor for T3 rectal/rectosigmoid cancer. Anticancer Res 2008;28:1773-1778. (Pubitemid 351892883)
12. Hermanek P, Henson DE, Hutter RVP, et al, eds. International Union Against Cancer (UICC): TNM Supplement 1993. A Commentary on Uniform Use. Berlin, Germany. Springer Verlag; 1993:122.
13. Jagoditsch M, Lisborg P, Jatzko GR, et al. Long-term prognosis for colon cancer related to consistent radical surgery: multivariate analysis of clinical, surgical and pathologic variables. World J Surg 2000;24: 1264-1270.
14. Schippinger W, Samonigg H, Schaberl-Moser R, et al. Austrian Breast and Colorectal Cancer Study Group. A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer. Br J Cancer 2007;97:1021-1027. (Pubitemid 47587021)
15. Schippinger W, Jagoditsch M, Sorré C, et al. Austrian Breast and Colorectal Cancer Study Group. A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer. Br J Cancer 2005;92:1655-1662. (Pubitemid 40756475)
16. Fielding LP, Arsenault PA, Chapuis PH, et al. Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol 1991;6:325-344.
17. Jagoditsch M, Pozgainer P, Klingler A, et al. Impact of blood transfusions on recurrence and survival after rectal cancer surgery. Dis Colon Rectum 2006;49:1116-1130. (Pubitemid 44221295)
18. Sauer R, Fietkau R, Wittekind C, et al. German Rectal Cancer Group. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94. Colorectal Dis 2003;5: 406-415. (Pubitemid 37080645)
19. Sauer R, Becker H, Hohenberger W, et al. German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740.
20. Li M, Li JY, Zhao AL, Gu J. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas. Oncology 2007;73:52-57. (Pubitemid 351465600)
21. Merkel S, Mansmann U, Siassi M, et al. The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 2001;16:298-304. (Pubitemid 32927002)
22. Harewood GC, Kumar KS, Clain JE, et al. Clinical implications of quantification of mesorectal tumor invasion by endoscopic ultrasound: all T3 rectal cancers are not equal. J Gastroenterol Hepatol 2004;19: 750-755. (Pubitemid 38981395)
23. Shinto E, Ueno H, Hashiguchi Y, et al. The subserosal elastic lamina: an anatomic landmark for stratifying pT3 colorectal cancer. Dis Colon Rectum 2004;47:467-473. (Pubitemid 38436652)
24. Greene FL, Stewart AK, Norton HJ. A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients. Ann Surg 2002;236:416-421.
25. Eriksen MT, Wibe A, Haffner J, Wiig JN. Norwegian Rectal Cancer Group. Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy. Dis Colon Rectum 2007;50:156-167. (Pubitemid 46227211)